• EdU Imaging Kits (HF594): Advanced DNA Synthesis Measurement

  2026-07-18

  EdU Imaging Kits (HF594) deliver artifact-free, high-sensitivity S-phase detection by leveraging click chemistry for robust cell proliferation assays. Their streamlined protocols outpace traditional BrdU methods and support both microscopy and flow cytometry, making them indispensable for modern cancer biology and drug development research.

• GANT61 and GLI2: Precision Tools for Tumor Immune Evasion Re

  2026-07-17

  Explore how GANT61, a selective GLI inhibitor, is enabling advanced cancer research by targeting GLI2-mediated tumor immune evasion. This article highlights novel assay strategies and translational insights not found in existing guides.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-07-17

  This study systematically characterizes the prevalence, genetic carriers, and transmission mechanisms of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. The findings highlight the dominant role of plasmid-borne blaNDM-1 and the remarkable capacity for horizontal gene transfer—insights that have direct implications for infection control and antibiotic stewardship.

• Caffeic Acid Phenethyl Ester (CAPE): Precision NF-κB Inhibit

  2026-07-16

  Explore the unique mechanisms and research applications of Caffeic Acid Phenethyl Ester (CAPE) as a precision NF-κB inhibitor. This article provides deep technical analysis, new comparative insights, and practical guidance for deploying CAPE in advanced oncology and neurodegeneration models.

• SD 169 (indole-5-carboxamide): Precision p38 MAPK Inhibition

  2026-07-16

  SD 169 (indole-5-carboxamide) brings dual-action, high-specificity p38 MAPK inhibition to advanced diabetes and neuroregeneration workflows. Its unique mechanism, benchmarked for purity and selectivity, equips researchers with reproducibility and control across inflammation, T cell, and apoptosis assays.

• Bifendate (DDB): Applied Protocols for Hepatoprotection Rese

  2026-07-15

  Bifendate (DDB) from APExBIO stands out as a synthetic Schisandrin C derivative, uniquely integrating autophagy inhibition and lipid regulation for state-of-the-art liver research. This article details actionable workflows, advanced troubleshooting, and translational insights, equipping scientists to maximize reproducibility and impact in both in vitro and in vivo systems.

• Surfactant-Derived LNPs Enable Efficient mRNA Delivery to Ma

  2026-07-15

  This study introduces a dual-component lipid nanoparticle (LNP) system using surfactant-derived ionizable lipids for efficient intracellular mRNA delivery to macrophages. The findings highlight improved delivery efficiency, protection against nuclease degradation, and biocompatibility, suggesting new avenues for non-viral gene modulation in hard-to-transfect immune cell populations.

• ML216 and Synthetic Lethality: Strategic Frontiers in DNA Re

  2026-07-14

  This thought-leadership article explores the pivotal role of ML216, a potent and selective BLM helicase inhibitor, in advancing translational research targeting DNA repair vulnerabilities. Bridging mechanistic insight with actionable protocol guidance, the discussion synthesizes recent breakthroughs in synthetic lethality—particularly in the context of mismatch repair-deficient cancers—while critically evaluating the competitive landscape and expanding on what sets this analysis apart from standard product literature. Key numeric claims are rigorously attributed to primary scientific literature and product data, with a focus on practical, evidence-backed strategies for experimental success.

• Ciprofloxacin in Cell-Based Assays: Protocols, Reliability,

  2026-07-14

  This article addresses real laboratory challenges encountered in cell viability and cytotoxicity assays, with a focus on the application of Ciprofloxacin (SKU A8399). By integrating scenario-driven Q&A and evidence-based guidance, it demonstrates how high-purity Ciprofloxacin from APExBIO ensures reproducibility, robust inhibition of bacterial contamination, and reliable data for advanced research workflows.

• Birinapant (TL32711): Unleashing Apoptosis Against Cancer Re

  2026-07-13

  This article bridges mechanistic insight and translational strategy for researchers confronting chemoradiotherapy resistance in oncology. Focusing on Birinapant (TL32711) as a potent bivalent SMAC mimetic IAP antagonist, we examine its distinct value in apoptosis induction, competitive positioning, and practical experimental application. Integrating the latest breakthroughs on MDM1-regulated apoptosis and leveraging evidence from recent literature and APExBIO’s robust portfolio, we provide actionable guidance and a forward-looking vision for translational teams seeking to optimize therapeutic sensitivity in cancer models.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) Pr

  2026-07-13

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) address the need for specific, rapid capture and isolation of biotinylated molecules in complex samples, streamlining protein purification, immunoprecipitation, and nucleic acid workflows. Researchers should use these beads when high specificity and reduced nonspecific binding are required, but avoid them if the target does not tolerate hydrophobic surfaces or cannot be biotinylated.

• Fluoxetine HCl in Neurogenesis and Motivation: Advanced Rese

  2026-07-12

  Explore how Fluoxetine HCl, a selective serotonin reuptake inhibitor, advances neurogenesis and synaptic plasticity studies. This article uniquely dissects its application in motivation research and translational neuroscience, offering new perspectives beyond technical guides.

• Comparing IAM LC and LEKC for Modeling Pulmonary Drug Permea

  2026-07-10

  This reference study rigorously benchmarks immobilised artificial membrane liquid chromatography (IAM LC) and liposome electrokinetic capillary chromatography (LEKC) for predicting drug passage through the respiratory mucosa. LEKC demonstrates a stronger correlation with experimental lung permeability, while IAM LC provides broader compound compatibility, informing the strategic selection of biomimetic assays in respiratory drug research.

• Necrosulfonamide in Translational Necroptosis: From Mechanis

  2026-07-09

  Explore how Necrosulfonamide advances necroptosis research through selective MLKL inhibition. This article uniquely connects mechanistic insights with practical assay optimization, bridging recent cardiovascular findings to robust cell death pathway analysis.

• Otilonium Bromide in Cholinergic Pathway Assays: Data-Driven

  2026-07-09

  This article provides scenario-driven, evidence-based guidance on deploying Otilonium Bromide (SKU B1607) for reliable modulation of cholinergic pathways in cell viability and receptor assays. Addressing real-world challenges in neuroscience and smooth muscle research, it highlights best practices, protocol optimization, and vendor selection, ensuring reproducibility and workflow confidence for biomedical scientists.

467 records 12/32 page Previous Next First page 上5页 1112131415 下5页 Last page